BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2020
View Archived Issues
Drugging resistant androgen receptors
Read More
BioVaxys and Ohio State University collaborate to study SARS-CoV-2 vaccine candidate BVX-0320
Read More
Congenital hydrocephalus has significant genetic component
Read More
[18F]3-F-4-AP shows promise as PET tracer for imaging K+ channels in demyelination in primate models
Read More
Xintela's XSTEM shows therapeutic effect in preclinical pig model of ARDS
Read More
Positive topline data from phase I/IIa study of IVMED-80 eyedrops
Read More
Positive data presented from phase III GEMINI 1 and 2 studies of AGN-190584
Read More
First patient dosed in phase II study of BBP-589
Read More
Hepagene Therapeutics patents IAP inhibitors
Read More
Aligos Therapeutics presents new PRMT5 inhibitors
Read More
Merck & Co. synthesizes new compounds for HIV infection
Read More
CDK2/cyclin E inhibitors synthesized by Incyte
Read More
DermBiont patents compounds for infections and skin disorders
Read More
Australian regulatory authorities approve phase I study of APL-1501
Read More
Recruitment completed in phase III FORTRESS study of balixafortide
Read More
AUR-102: a potent and selective CDK7 inhibitor for cancer treatment
Read More
DS-7300a shows potent antitumor effects in B7-H3-expressing cancer models
Read More
NMBS-2: a selective and potent HPK1 inhibitor for enhancing antitumor immunity
Read More
Scandion Oncology initiates phase Ib pancreatic cancer study of SCO-101
Read More
Boehringer Ingelheim initiates phase II study of BI-764198 in patients with COVID-19
Read More
New tool probes neurodevelopmental disorder genes
Read More
Positive prospective results presented from COVID-19 outpatient trial of REGN-COV2
Read More
Aerie initiates phase IIb COMET-1 trial of AR-15512 ophthalmic solution
Read More
